Crossmark

Kinome chemoproteomics characterization of pyrrolo[3,4- <i>c</i> ]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3

Published Online: 2017-12-20

Published Print: 2017-12-20

Authors

Golkowski, Martin https://orcid.org/0000-0002-0996-1655
Perera, Gayani K

Vidadala, Venkata Narayana

Ojo, Kayode K

Van Voorhis, Wesley C

Maly, Dustin J

Ong, Shao-En https://orcid.org/0000-0003-3314-5903
Funding

Funding for this research was provided by:

National Institutes of Health (AI080625)

National Institutes of Health (AI110743-01)

National Institutes of Health (AI123690)

National Institutes of Health (R01AI111341)

National Institutes of Health (R01GM083926)

National Institutes of Health (R21CA177402)

National Institutes of Health (R21EB018384)

National Institutes of Health (R01GM086858)

National Institutes of Health (AI080625)

National Institutes of Health (AI110743-01)

National Institutes of Health (AI123690)

National Institutes of Health (R01AI111341)

National Institutes of Health (R01GM083926)

National Institutes of Health (R21CA177402)

National Institutes of Health (R21EB018384)

National Institutes of Health (R01GM086858)
License Information

Version of Record valid from 2017-12-20

Accepted Manuscript valid from 2018-12-20
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Martin Golkowski (ORCID)

: Shao-En Ong (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 22 August 2017; Accepted 27 November 2017; Advance Article published 20 December 2017; Version of Record published 12 February 2018

Document is current